Analysis and Factor Affecting Cost of Chemotherapy in Breast Cancer

  • heny dwi arini sekolah tinggi farmasi mahaganesha
  • Agustina Nila Yuliawati
  • Balqish Fathoum Medinna

Abstract

The high incidence of breast cancer poses an economic burden to patients as well as the government due to expensive and periodic medical expenses. Therefore, a cost analysis is needed which can provide input for estimated costs to be incurred in the future. The purpose of this study was to determine cost estimates and factors that affect chemotherapy costs in breast cancer patients. Observational study with a cross-sectional design using data on treatment episodes for breast cancer patients during the 2022 period at X Hospital. The purposive sampling method was used by fulfilling the inclusion and exclusion criteria of the study. Retrospective data collection from medical records and patient billing. Data analysis included patient demographic characteristics, treatment cost calculations, and factors affecting costs with a multivariate linear regression test. The results showed that the highest average total cost of breast cancer chemotherapy at X Hospital for the 2022 period was IDR 34,040,751 at stage III class 1, and the factor that affected chemotherapy costs was age (p = 0.021).

References

Adel, N. (2017). Overview of Chemotherapy-induced Nausea and Vomiting and Evidence-based therapies. The American Journal of Managed Care, 23(14), 259–265.
Al Ayubi, C.M.S.H., 2020. Karakteristik Penderita Kanker Payudara Berdasarkan Usia, Riwayat Menopause, Dan Gambaran Histopatologi Di Rsud Al-Ihsan Periode Agustus–November 2019.
American Cancer Society, 2016, Available from: https://www.cancer.org/ content/dam/CRC/PDF/Public/8577.00.pdf
Dewi, N.L.P.R., Ariawati, K. and Niruri, R., 2015. Efektivitas Ondansetron dalam Menangani Mual dan Muntah Pasca Kemoterapi Metotreksat Dosis Tinggi pada Pasien Anak dengan Leukemia Limfoblastik Akut di Rumah Sakit Umum Pusat Sanglah. Jurnal Farmasi Udayana, 3(2), p.279783.
Dewi, S. and Ambarriani, A.M.A.S., 2019. Disparitas Tarif INA-CBGs dan Tarif Rumah Sakit Pasien BPJS Rawat Inap di RSUD Kolonodale, Kabupaten Morowali Utara. Jurnal Kebijakan Kesehatan Indonesia: JKKI, 8(02).
Dinas Kesehatan Provinsi Bali. (2021). Profil Kesehatan Provinsi Bali. Denpasar. Diambil dari https://www.diskes.baliprov.go.id/profil-kesehatan-provinsi-bali
Dyah, R.I., Wahyono, D. and Andayani, T.M., 2014. Analisis Biaya Terapi Pasien Diabetes Melitus Rawat Inap. JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice), 4(1), pp.55-62.
Gelgel, J.P.P. and Christian, I.S., 2020. Karakteristik Kanker Payudara Wanita di Rumah Sakit Umum Pusat Sanglah Denpasar Tahun 2014-2015. J Med Udayana, 9(3), pp.52-57.
International Agency for Research on Cancer. GLOBOCAN 2020. Indonesia - Global Cancer Observatory. (diakses 11 Februari 2021). Tersedia dari: https://gco.iarc.fr/today/data/factsheets/populations/360-indonesia-factsheets.pdf.
Katzung, B. G. (2012) Schedule 1 Controlled Drugs I. 12th Editi. Edited by P. Bertram G. Katzung, MD. San Francisco: McGraw Hill Medical.
Katzung, B. G. (2012) Schedule 1 Controlled Drugs I. 12th Editi. Edited by P. Bertram G. Katzung, MD. San Francisco: McGraw Hill Medical.
Mulyani, & Nuryani. (2016). Kanker Payudara dan PMS pada Kehamilan. Yogyakarta : Nuha Medika.
Puspandari, D.A., Mukti, A.G. and Kusnanto, H., 2015. Faktor-Faktor yang Mempengaruhi Biaya Obat Pasien Kanker Payudara di Rumah Sakit di Indonesia. Jurnal Kebijakan Kesehatan Indonesia: JKKI, 4(3), pp.104-108.
Putranto, R. and Laksono Trisnantoro, Y.H., 2017. Penghematan Biaya Perawatan Pasien Kanker Terminal Evaluasi Biaya Kemoterapi Pasien Early Breast Cancer di RSUD Tugurejo Semarang Periode Juli-Desember Dewasa Melalui Konsultasi Tim Paliatif di Rumah Sakit Dr. Cipto Mangunkusumo. Jurnal Penyakit Dalam Indonesia| Vol, 4(1).
Rezaee, M., Hill, R. P., & Jaffray, D. A. (2017). The Exploitation of Low-Energy Electrons in Cancer Treatment. Radiation Research, 188(2), 123–143. doi:10.1667/rr14727.1
Silitonga, M., Chandra, D., Fitri, R. and Nanda, F., 2022. Analisis Faktor yang Mempengaruhi Pertumbuhan Kultur Sel Cho (Chinase Hamster Ovarium) pada Pembuatan Obat Trastuzumab Di Pt. Bio Farma. Jurnal Farmanesia, 9(1), pp.61-67.
Sonang, S., Purba, A.T. and Pardede, F.O.I., 2019. Pengelompokan Jumlah Penduduk Berdasarkan Kategori Usia Dengan Metode K-Means. Jurnal Tekinkom (Teknik Informasi dan Komputer), 2(2), pp.166-172.
Ulfa, L.L., Hendriyono, F.X. and Priyono, S.H., 2020. Perbedaan Jumlah Trombosit sebelum dan sesudah Kemoterapi Neoadjuvan pada Pasien Kanker Payudara. Homeostasis, 3(1), pp.15-22.
WHO in International Agency for Research on Cancer. Global Cancer Obsevatory of Breast Cancer 2020. (diakses 11 Februari 2021). Tersedia dari : https://gco.iarc.fr/today/data/ factsheets/cancers/20-Breast-fact-sheet.pdf.Kemenkes, RI. 2013. Pedoman Penerapan Kajian Farmakoekonomi. Kementrian Kesehatan RI, Jakarta, 10-28.
Published
2023-12-31
PDF (Bahasa Indonesia)
Abstract views: 76
downloads: 87